FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Outi Paija

Research Profile

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Finland

Disorders

Co-author Network

Publications

TOP 3
R Coleman; N Davidson; R de Boer; H Eidtmann; J Forbes; Antonio Frassoldati; A Llombart; N Martin; A Modi; P Neven; Outi Paija; H P Sleeboom; G von Minckwitz; C Barrios; I Campbell; N Bundred
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.
Antonio Llombart; Jeroen Mebis; Joel Miller; Ines Deleu; Antonio Frassoldati; Guy Jerusalem; Outi Paija; Nora Schenk; Harm Peter Sleeboom; Patrick Neven
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.
Pia Vihinen; Atte Kivisaari; Leena Koulu; Outi Paija; Heikki Aho
Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Outi Paija (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R Coleman; N Davidson; R de Boer; H Eidtmann; J Forbes; Antonio Frassoldati; A Llombart; N Martin; A Modi; P Neven; Outi Paija; H P Sleeboom; G von Minckwitz; C Barrios; I Campbell; N Bundred
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):398-405.
2012: Antonio Llombart; Jeroen Mebis; Joel Miller; Ines Deleu; Antonio Frassoldati; Guy Jerusalem; Outi Paija; Nora Schenk; Harm Peter Sleeboom; Patrick Neven
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.
Clinical breast cancer 2012;12(1):40-8.
2011: Pia Vihinen; Atte Kivisaari; Leena Koulu; Outi Paija; Heikki Aho
Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.
Journal of medical case reports 2011;5():243.
2011: Pirkko Kellokumpu-Lehtinen; Ulla Puistola; Outi Paija; Eeva Taimela; Outi Hirvonen; Sari Raassina; Henrik Riska
Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(1):149-53.
2009: Heikki Joensuu; Pirkko Kellokumpu-Lehtinen; Riikka Huovinen; Arja Jukkola-Vuorinen; Minna Tanner; Raija Asola; Riitta Kokko; Johan Ahlgren; Päivi Auvinen; Akseli Hemminki; Outi Paija; Leena Helle; Lauri Nuortio; Kenneth Villman; Greger Nilsson; Sirpa-Liisa Lahtela; Kaisa Lehtiö; Marjo Pajunen; Paula Poikonen; Paul Nyandoto; Vesa Kataja; Petri Bono; Mika Leinonen; Henrik Lindman
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.
The lancet oncology 2009;10(12):1145-51.
2007: Pirkko Kellokumpu-Lehtinen; Ulla Puistola; Outi Paija; Eeva Taimela; Outi Hirvonen; Sari Raassina; Henrik Riska
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2007;123(18):2239-46.
2005: Outi Paija; Kari Laine; Eeva-Riitta Kultalahti; Mika Leinonen; Risto Huupponen; Ariel Gordin; Kari Reinikainen
Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR.
Clinical neuropharmacology 2005;28(3):115-9.
2004: Outi Paija
[Does a doctor care about a cancer patient's pain?].
Duodecim; lääketieteellinen aikakauskirja 2004;120(6):665-71.
2003: Risto Huupponen; Outi Paija; Markku Salonen; Harry Björklund; Juha Rouru; Markku Anttila
Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
Drugs in R&D 2003;4(6):339-45.